Calyx Provides Update on 2013 Resonance(R) Carinata Contracting Program

Calyx Bio-Ventures Inc. (TSX VENTURE:CYX) ("Calyx" or the "Company") is pleased
to provide an update on the Resonance(R) carinata growing program currently
being conducted by its majority-owned subsidiary, Agrisoma Biosciences Inc.
("Agrisoma").


The 2013 growing program was introduced on March 26, 2013, at a day-long event
held in Swift Current, Saskatchewan, in connection with the Government of
Saskatchewan's Ministry of Agriculture, the Saskatchewan Mustard Development
Commission, and Prairie Gold. The presentation covered a range of topics of
interest to potential growers, including agronomics, Resonance(R) carinata
breeding and varieties, crop inputs (fertilizer, weed & insect control), crop
insurance, and grower experiences from last year.


The 2013 contracting program is in progress. Spring has been colder and longer
than normal this year. Farmers in Alberta, Saskatchewan and Manitoba usually
begin planting in late April in southern areas, but 2013 planting has been
delayed for many growers. The delayed planting season and resulting shortened
growing season is not expected to impact the ability of growers to successfully
cultivate Resonance(R) carinata in the current year. A further update will be
provided when the growing season progresses.


About Calyx 

Calyx Bio-Ventures Inc. (TSX VENTURE:CYX) is an agricultural technology company
focused on renewable fuels including biojet and biodiesel. Calyx's
majority-owned operating subsidiary, Agrisoma Biosciences Inc., is producing a
new proprietary non-food energy feedstock crop, Resonance(R) carinata, which
yields oil that can be refined into fuels that work in existing engines as a 100
percent petroleum substitute. From seed to sky, fuels produced from Resonance(R)
carinata substantially reduce carbon and other harmful emissions, and help to
reduce global petroleum dependence. For further information about Calyx, please
visit www.calyxbio.com.


Forward-Looking Statements: This document contains certain forward-looking
statements concerning Calyx and/or Agrisoma, as well as other expectations,
plans, goals, objectives, information or statements about future events,
conditions, results of operations or performance that may constitute
"forward-looking statements" or "forward-looking information" under applicable
securities legislation. Such statements or information involve substantial known
and unknown risks and uncertainties, certain of which are beyond Calyx's and/or
Agrisoma's control, including general business, economic, competitive, political
and social uncertainties; the delay or failure to receive regulatory approvals,
the characteristics and viability for bio-fuel development, the willingness of
third parties to conclude agreements with Calyx and/or Agrisoma on terms that
are acceptable to management of Calyx and/or Agrisoma, and the ability of Calyx
and/or Agrisoma to secure sufficient future funding to carry out all of its
business plans.


Such forward-looking statements or information are based on a number of
assumptions, which may prove to be incorrect. In addition to other assumptions
identified in this news release, assumptions have been made regarding, among
other things, commodity prices, operating conditions, capital and other
expenditures, and project development activities.


Although Calyx and/or Agrisoma believes that the expectations reflected in such
forward-looking statements or information are reasonable, undue reliance should
not be placed on forward-looking statements because Calyx and/or Agrisoma can
give no assurance that such expectations will prove to be correct.
Forward-looking statements or information are based on current expectations,
estimates and projections that involve a number of risks and uncertainties which
could cause actual results to differ materially from those anticipated by Calyx
and/or Agrisoma and described in the forward-looking statements or information.


The forward-looking statements or information contained in this news release are
made as of the date hereof and Calyx and/or Agrisoma undertakes no obligation to
update publicly or revise any forward-looking statements or information, whether
as a result of new information, future events or otherwise unless so required by
applicable securities laws or the TSX Venture Exchange. The forward-looking
statements or information contained in this news release are expressly qualified
by this cautionary statement.


This press release shall not constitute an offer to sell, nor the solicitation
of an offer to buy, any securities in the United States, nor shall there be any
sale of securities mentioned in this press release in any state in the United
States in which such offer, solicitation or sale would be unlawful prior to
registration or qualification under the securities laws of any such state.


FOR FURTHER INFORMATION PLEASE CONTACT: 
Calyx Bio-Ventures Inc.
W. Hugh Notman
President & CEO
604-689-2495
hnotman@calyxbio.com


Calyx Bio-Ventures Inc.
Keir Reynolds
Investor Relations
778-998-9242
kreynolds@calyxbio.com
www.calyxbio.com
Calyx Ventures (TSXV:CYX)
Graphique Historique de l'Action
De Mai 2024 à Juin 2024